Gerald Soff

Affiliations: 
Northwestern University, Evanston, IL 
Area:
Cell Biology, Molecular Biology, Oncology
Google:
"Gerald Soff"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang TF, Khorana AA, Agnelli G, et al. (2023) Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction. The Oncologist
Basaran D, Boerner T, Suhner J, et al. (2021) Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Gynecologic Oncology
Kilpatrick K, Shaw JL, Jaramillo R, et al. (2020) Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data From Prospective Clinical Trials. Clinical Colorectal Cancer
Wang TF, Billett HH, Connors JM, et al. (2020) Approach to Cancer-Associated Thrombosis: Challenging Situations and Knowledge Gaps. The Oncologist
Bauersachs R, Khorana AA, Lee AYY, et al. (2020) Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban. Research and Practice in Thrombosis and Haemostasis. 4: 532-549
Mones JV, Soff G. (2019) Management of Thrombocytopenia in Cancer Patients. Cancer Treatment and Research. 179: 139-150
Carrier M, Soff G, Gal GL. (2019) Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants. Cancer Treatment and Research. 179: 103-115
Soff G. (2019) Thrombosis and Hemostasis in Cancer. Scope of the Problem and Overview. Cancer Treatment and Research. 179: 1-9
Khorana AA, Mones J, Soff GA. (2019) Preventing Venous Thromboembolism in Patients with Cancer. Reply. The New England Journal of Medicine. 380: 2181
Khorana AA, Soff GA, Kakkar AK, et al. (2019) Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. The New England Journal of Medicine. 380: 720-728
See more...